Client Management | Digital KYC | Transactions | Investor App | AUM & Brokerage Reports | Lead Management | Automated Follow-Ups | MF Research | Multi-Asset Tracking
Login
Get Started
Home Mf Research Uti Healthcare Fund Regular Plan Idcw Reinvestment
UTI MUTUAL FUND

Mutual Fund Research

UTI Healthcare Fund - Regular Plan - IDCW Reinvestment

UTI MUTUAL FUND Equity Equity Sectoral Thematic

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,028.16 +2.82%
Two Week 2026-10-19 ₹1,000.00 ₹1,051.40 +5.14%
One Month 2026-10-05 ₹1,000.00 ₹1,011.26 +1.13%
Three Months 2026-08-05 ₹3,000.00 ₹2,965.41 -1.15%
Six Months 2026-05-07 ₹6,000.00 ₹6,149.18 +2.49%
One Year 2025-11-03 ₹12,000.00 ₹13,266.31 +10.55%
Three Year 2023-11-06 ₹36,000.00 ₹45,134.19 +25.37%
Five Year 2021-11-08 ₹60,000.00 ₹96,846.30 +61.41%
Ten Year 2016-11-07 ₹120,000.00 ₹307,895.04 +156.58%
Since Inception 2000-01-04 ₹327,000.00 ₹3,085,543.51 +843.59%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 68.48%
Healthcare Services 23.31%
Other 5.87%
Chemicals & Petrochemicals 1.28%
Healthcare Equipment & Supplies 1.08%

Top Holdings

Company-wise portfolio exposure

EQ - SUN PHARMACEUTICALS INDUSTRIES 7.62%
EQ - DIVIS LABORATORIES LTD. 6.15%
EQ - DR REDDYS LABORATORIES LTD. 5.24%
EQ - AJANTA PHARMA LTD. 4.81%
EQ - GLAND PHARMA LTD. 4.06%
EQ - ALKEM LABORATORIES LTD 3.70%
EQ - APOLLO HOSPITALS ENTERPRISE LT 3.03%
EQ - CAPLIN POINT LABORATORIES LTD 3.02%
EQ- GLOBAL HEALTH LTD. 2.96%
EQ - LUPIN LTD. 2.89%
EQ - IPCA LABORATORIES LTD. 2.81%
EQ - MAX HEALTHCARE INSTITUTE LTD 2.80%
EQ - COHANCE LIFESCIENCES LIMITED 2.79%
EQ - MARKSANS PHARMA LTD. 2.25%
EQ - RAINBOW CHILDRENS MEDICARE LTD 2.21%
EQ - GLENMARK PHARMACEUTICALS LTD. 2.12%
EQ- JUPITER LIFE LINE HOSPITALS LTD 2.09%
EQ - AUROBINDO PHARMA LTD. 2.07%
EQ - FORTIS HEALTHCARE LTD. 2.02%
EQ - PROCTOR & GAMBLE HEALTH LTD 1.95%
EQ - ANTHEM BIOSCIENCES LTD 1.80%
EQ - ASTER DM QUALITY CARE LIMITED 1.76%
EQ - DR LAL PATHLABS LTD. 1.67%
EQ - BIOCON LTD. 1.62%
EQ - METROPOLIS HEALTHCARE LTD 1.47%
EQ - WINDLAS BIOTEC LTD 1.42%
EQ - CIPLA LTD. 1.41%
EQ - BLUE JET HEALTHCARE LTD 1.41%
EQ - ALEMBIC PHARMACEUTICALS 1.40%
EQ - VIYASH SCIENTIFIC LTD 1.39%
EQ - VIJAYA DIAGNOSTIC CENTRE LTD 1.33%
EQ - SUDEEP PHARMA LIMITED 1.28%
EQ - SAI LIFE SCIENCES LTD 1.26%
EQ - ERIS LIFESCIENCES LTD 1.13%
EQ - LAXMI DENTAL LIMITED 1.08%
EQ - MANIPAL HEALTH ENTERPRISES LIMITED 1.05%
EQ - AARTI PHARMALABS LTD 1.00%
EQ - PFIZER LIMITED 0.93%
EQ - ORCHID PHARMA LTD. 0.71%
EQ - SANOFI CONSUMER HEALTHCARE INDIA LTD 0.67%
EQ - JUBILANT PHARMOVA LIMITED 0.65%
EQ - INDEGENE LTD 0.50%
EQ - SYNGENE INTERNATIONAL LTD. 0.42%
EQ - EMCURE PHARMACEUTICALS LTD 0.20%
CLEARING CORPORATION OF INDIA LTD. STD - MARGIN 0.02%
NET CURRENT ASSETS 5.85%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
13.35%
Return volatility
β
Beta
0.92
Benchmark sensitivity
S
Sharpe Ratio
1.41
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Peer Comparison

Compare similar mutual funds by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Nippon India Taiwan Equity Fund - Regular Plan - Growth 59.11% 48.18% 22.89%
HDFC Pharma And Healthcare Fund - Regular Plan - Growth 22.21% 29.08% 28.07%
Kotak Healthcare Fund - Regular Plan - Growth 21.83% 0.00% 19.25%
ICICI Prudential US Bluechip Equity Fund - Regular Plan - Growth 20.30% 18.34% 15.87%
Nippon India - Japan Equity Fund - Regular Plan - Growth 20.05% 20.38% 8.48%
SBI Automotive Opportunities Fund - Regular Plan - Growth 18.72% 0.00% 10.86%
Mirae Asset Healthcare Fund - Regular Plan - Growth 17.38% 22.11% 20.05%
Whiteoak Capital - Pharma And Healthcare Fund - Regular Plan - Growth 17.07% 0.00% 20.11%
Bajaj Finserv Healthcare Fund - Regular Plan - Growth 16.66% 0.00% 8.50%
SBI Healthcare Opportunities Fund - Regular Plan - Growth 16.50% 23.22% 15.44%

Returns are historical and do not guarantee future performance.

View All Equity Sectoral Thematic Funds

Fund Family

Compare schemes from UTI MUTUAL FUND by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
UTI Silver Exchange Traded Fund - Regular Plan - Growth 17.69% 33.72% 25.93%
UTI Silver ETF Fund Of Fund - Regular Plan - Growth 16.27% 32.81% 24.96%
UTI Healthcare Fund - Regular Plan - IDCW Payout 13.25% 22.31% 11.32%
UTI Healthcare Fund - Regular Plan - IDCW Reinvestment 13.25% 0.00% 10.27%
UTI Healthcare Fund - Regular Plan - Growth 13.25% 22.31% 12.39%
UTI Gold Exchange Traded Fund - Regular Plan - Growth 13.21% 29.98% -10.21%
UTI Gold ETF Fund Of Fund - Regular Plan - Growth 12.13% 29.47% 26.56%
UTI Money Market Fund - Regular Plan - Annual IDCW Payout 6.25% 7.20% 5.86%
UTI Money Market Fund - Regular Plan - Annual IDCW Reinvestment 6.25% 0.00% 6.18%
UTI Money Market Fund - Regular Plan - Growth 6.25% 7.03% 26.83%

Returns are historical and do not guarantee future performance.

View All UTI MUTUAL FUND Funds

Scheme Objective

The investment mandate and purpose of this scheme

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.22%
Expense Ratio (Direct)
1.34%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare TRI

Exit Load

Charges that may apply when you redeem units

1.00% if redeemed before 30 days from the date of allotment. Nil if redeemed on or after 30 days from the date of allotment
Top AMC/Fund Houses
360 ONE Mutual Fund AMC logo
360 ONE Mutual Fund
AUM
₹13,053 Cr
Age
15+ Years
Aditya Birla Sun Life Mutual Fund AMC logo
Aditya Birla Sun Life Mutual Fund
AUM
₹4.36 Lakh Cr
Age
31+ Years
Helios Mutual Fund AMC logo
Helios Mutual Fund
AUM
₹9,401 Cr
Age
1–2 Years
Bandhan Mutual Fund AMC logo
Bandhan Mutual Fund
AUM
₹1.78+ Lakh Cr
Age
4 Years
view all

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?